Strong growth both organic and through acquisitions
AddLife´s Interim Report for Q2 2021 is now available online at the company website. The Interim Report can be downloaded in pdf version.
Visit reports-en.add.life/delarsrapport-q2-2021
1 APRIL -
Net sales increased by 82 percent to
SEK 2,276m (1,248), of which organic growth amounted to 22 percent and acquired growth amounted to 63 percent.- EBITA increased by 83 percent to
SEK 332m (181), corresponding to an EBITA-margin of 14.6 percent (14.5). Transaction costs and stamp duty ofSEK 53m has been charged to the result. -
Profit after tax increased by 49 percent to
SEK 178m (120). -
Earnings per share amounted to
SEK 1.47 (1.07). -
Cash flow from operating activities amounted to
SEK 200m (128). -
Two acquisitions were completed during the quarter,
Vision Ophthalmology Group and Helathcare 21. The acquisitions are expected to add annual net sales ofSEK 2,400m and EBITA of approximatelySEK 310m . The acquisitions have been financed through new credits, new share issue of Class B shares and existing shares held in treasury.
1 JANUARY -
Net sales increased by 74 percent to
SEK 4,012m (2,301), of which organic growth amounted to 37 percent and acquired growth amounted to 42 percent.- EBITA increased by 129 percent to
SEK 658m (287), corresponding to an EBITA-margin of 16.4 percent (12.5). -
Profit after tax increased by 133 percent to
SEK 404m (174). -
Earnings per share amounted to
SEK 3.46 (1.55). Earnings per share for the last 12 months amounted toSEK 6.55 (4.63). -
Cash flow from operating activities amounted to
SEK 384m (208). - The equity ratio was 38 percent (46).
- Return on working capital (P/WC) amounted to 115 percent (122).
For more information, contact;
Kristina Willgård, CEO, kristina.willgard@add.life, +46 70 510 12 23
www.add.life
Teleconference
Investors. analysts and the media are invited to a teleconference at which CEO
The teleconference will be at
If you wish to participate via teleconference, please follow this link>>
Or call in (only sound) +46 8 505 376 58 Conferens-ID: 321 695 644#
The presentation is also available on AddLife YouTube >>
This information is information that
https://news.cision.com/addlife/r/interim-report-1-january---30-june-2021,c3385123
https://mb.cision.com/Main/13919/3385123/1445099.pdf
(c) 2021 Cision. All rights reserved., source